SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

24 Jun 2015 15:56

RNS Number : 1380R
Rentokil Initial PLC
24 June 2015
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Please complete all relevant boxes in block capital letters.

Β 

1. Name of the issuer

Β 

Rentokil Initial plc

Β 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

Pursuant to (i) and (iii) above

Β 

3. Name of person discharging managerial responsibilities/director

Β 

Martin Sawkins - PDMR

Β 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

Not applicable

Β 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

Pursuant to 3.above

Β 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

Ordinary shares of 1 pence each

Β 

7. Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

Β 

Martin Sawkins

Β 

8 State the nature of the transaction

Β 

Exercise of Performance share plan vested award 2012 - Final vested award 8 May 2015 - 103,254 and sale of shares to meet tax liabilities.

Β 

Β 

9. Number of shares, debentures or financial instruments relating to shares acquired

Β 

103,254 Performance shares plan award 2012 - awarded after application of performance conditions

Β 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

0.00566%

Β 

11. Number of shares, debentures or financial instruments relating to shares disposed

.

48,701 sold to meet tax liabilities and dealing costs. Balance shares held 54,553

Β 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)Β 

Β 

0.00267%

Β 

13. Price per share or value of transaction

Β 

150.5p

Β 

14. Date and place of transaction

Β 

19 June 2015, London

Β 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

84,757 Ordinary shares - 0.00465%

Β 

16. Date issuer informed of transaction

Β 

22 June 2015

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

Β 

17. Date of grant

Β 

N/A

Β 

18. Period during which or date on which it can be exercised

Β 

N/A

Β 

19. Total amount paid (if any) for grant of the option

Β 

N/A

Β 

20. Description of shares or debentures involved (class and number)

Β 

N/A

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

N/A

Β 

22. Total number of shares or debentures over which options held following notification

Β 

N/A

Β 

23. Any additional information

Β 

Sale of 48,701 ordinary shares to satisfy tax liability and dealing costs

24. Name of contact and telephone number for queries

Β 

Alexandra Laan, Assistant Company Secretary - +44(0)1276 607444

Β 

25. Name of authorised official of issuer responsible for making notification and date of notification

Β 

Daragh Fagan - General Counsel & Company Secretary - 24 June 2015

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBSGDLXUDBGUS
Date   Source Headline
25th Nov 20193:25 pmRNSHolding(s) in Company
14th Nov 20194:00 pmRNSHolding(s) in Company
8th Nov 20195:30 pmRNSHolding(s) in Company
8th Nov 20199:40 amRNSDirector/PDMR Shareholding
6th Nov 20195:00 pmRNSHolding(s) in Company
5th Nov 20195:10 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSAcquisition of Florida Pest Control, USA
31st Oct 20194:30 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Update
30th Sep 201910:20 amRNSBlock listing Interim Review
23rd Sep 201910:30 amRNSHolding(s) in Company
13th Sep 20194:00 pmRNSDirector/PDMR Shareholding
19th Aug 20193:15 pmRNSDirector/PDMR Shareholding
5th Aug 20191:58 pmRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSAppointment of Joint Corporate Broker
2nd Jul 201910:35 amRNSPost Stabilisation Notice
21st Jun 20197:00 amRNSDirectorate Change
11th Jun 201912:00 pmRNSHolding(s) in Company
31st May 20195:00 pmRNSHolding(s) in Company
30th May 20195:00 pmRNSDirector Declaration
17th May 20194:04 pmRNSDirector/PDMR Shareholding
15th May 20199:30 amRNSPre Stabilisation Notice
8th May 20192:30 pmRNSResult of AGM
29th Apr 201911:40 amRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSQ1 Trading Update
12th Apr 20196:25 pmRNSDirector/PDMR Shareholding - Replacement
11th Apr 20194:37 pmRNSDirector/PDMR Shareholding
10th Apr 20191:57 pmRNSDirector Declaration
1st Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
27th Mar 201911:18 amRNSAnnual Financial Report
25th Mar 20199:58 amRNSDirector/PDMR Shareholding
12th Mar 201912:17 pmRNSDirector/PDMR Shareholding
6th Mar 20192:00 pmRNSAdditional Listing
6th Mar 20191:05 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSInnovative good causes initiative
28th Feb 20195:15 pmRNSDirector/PDMR Shareholding
28th Feb 20197:05 amRNSDirectorate Changes and Appointment of Chairman
28th Feb 20197:00 amRNSFinal Results
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.